← Tickers

BNTX

BNTX — Ruslan Averin's Analysis · 1 entries

  1. BNTX Stock Analysis 2026: mRNA Oncology vs COVID Valuation
    ·7 min read

    BNTX Stock Analysis 2026: mRNA Oncology vs COVID Valuation

    BNTX stock broke above 200-day MA. With 47 oncology programs and $10B cash, the market still prices it as a COVID play — that gap is the trade.